PanGIA Biotech, Inc. ("PanGIA") announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine ...
The Gyne Cancer Company™ — today announced the publication of peer-reviewed evidence demonstrating that molecular signals ...
A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results ...
A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), the most common ...
Partnership expands access to breakthrough blood-based cancer screening into Superpower's comprehensive health check and personalized plans. SAN FRANCISCO, April 1, 2026 /PRNewswire/ -- Superpower, ...
This predictive model built on readily acquired clinical data provides encouraging results for the detection of residual disease. External validation and prospective studies implementing the model in ...
Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. It should be noted that the Galleri test not currently ...
Pancreatic cancer rarely announces itself early. It often grows in deep tissue, causes vague symptoms, and reaches medical ...
New Johns Hopkins research shows an AI-driven liquid biopsy analyzing genome-wide cfDNA fragment patterns can detect early ...